Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 21
(2)
◽
pp. 114-122
◽
2012 ◽
Vol 16
(11)
◽
pp. 1317-1321
◽
Keyword(s):